The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy

Journal of Gastrointestinal Surgery

Volumn 20, Issue 2, 2016, Pages 262-276

  McMillan, Matthew T ^a   Vollmer, Charles M ^a   Asbun, Horacio J ^b   Ball, Chad G ^c   Bassi, Claudio ^d   Beane, Joal D ^e   Berger, Adam C ^f   Bloomston, Mark ^g   Callery, Mark P ^h   Christein, John D ⁱ   Dixon, Elijah ^c   Drebin, Jeffrey A ^a   Castillo, Carlos Fernandez Del ^j   Fisher, William E ^k   Fong, Zhi Ven ^j   Haverick, Ericka ^g   House, Michael G ^e   Hughes, Steven J ^l   Kent, Tara S ^h   Kunstman, John W ^m   Malleo, Giuseppe ^d   McElhany, Amy L ^k   Salem, Ronald R ^m   Soares, Kevin ⁿ   Sprys, Michael H ^a   Valero, Vicente ⁿ   Watkins, Ammara A ^h   Wolfgang, Christopher L ⁿ   Behrman, Stephen W ^o   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF VERONA   (Italy)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ University of Alabama at Birmingham   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

more..

Author keywords

ISGPF grade C; Pancreatic fistula; Risk assessment

Indexed keywords

ADVERSE EFFECTS; AGED; ALGORITHM; COHORT ANALYSIS; FEMALE; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; PANCREATIC FISTULA; PANCREATICODUODENECTOMY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REOPERATION; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; COHORT STUDIES; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PANCREATIC FISTULA; PANCREATICODUODENECTOMY; PREDICTIVE VALUE OF TESTS; REOPERATION; RISK FACTORS; ROC CURVE;

EID: 84955480010     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-015-2884-2     Document Type: Article

References (29)

1. McMillan, M.T. and C.M. Vollmer, Jr., Predictive factors for pancreatic fistula following pancreatectomy. Langenbecks Arch Surg, 2014. 399(7): p. 811–24.
2. Bassi, C., et al., Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig Surg, 2004. 21(1): p. 54–9.
3. Denbo, J.W., et al., Toward defining grade C pancreatic fistula following pancreaticoduodenectomy: incidence, risk factors, management and outcome. HPB (Oxford), 2012. 14(9): p. 589–93.
4. Bassi, C., et al., Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery, 2005. 138(1): p. 8–13.
5. Hashimoto, Y. The Pancreas Club ISGPS Calculator. 2012 4/16/2014]; Available from: http://pancreasclub.com/calculators/isgps-calculator/.
6. Porembka, M.R., et al., Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the american college of surgeons national surgical quality improvement program. J Am Coll Surg, 2010. 210(3): p. 286–98.
7. Raval, M.V., et al., Improving American College of Surgeons National Surgical Quality Improvement Program risk adjustment: incorporation of a novel procedure risk score. J Am Coll Surg, 2010. 211(6): p. 715–23.
8. Bilimoria, K.Y., et al., Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg, 2013. 217(5): p. 833–42 e1-3.
9. Callery, M.P., et al., A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg, 2013. 216(1): 1–14.
10. ACS-NSQIP, User Guide for the 2013 ACS NSQIP Participant Use Data File (PUF). 2013.
11. Fuks, D., et al., Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg, 2009. 197(6): p. 702–9.
12. Pratt, W.B., M.P. Callery, and C.M. Vollmer, Jr., Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg, 2008. 32(3): p. 419–28.
13. Lin, J.W., et al., Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg, 2004. 8(8): p. 951–9.
14. DeOliveira, M.L., et al., Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg, 2006. 244(6): p. 931–7; discussion 937–9.
15. Gentilello, L.M., et al., Acute ethanol intoxication increases the risk of infection following penetrating abdominal trauma. J Trauma, 1993. 34(5): p. 669–74; discussion 674–5.
16. Szabo, G. and P. Mandrekar, A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res, 2009. 33(2): p. 220–32.
17. Guo, S. and L.A. Dipietro, Factors affecting wound healing. J Dent Res, 2010. 89(3): p. 219–29.
18. Marcus, S.G., H. Cohen, and J.H. Ranson, Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg, 1995. 221(6): p. 635–45; discussion 645–8.
19. Veillette, G., et al., Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience. Arch Surg, 2008. 143(5): p. 476–81.
20. Kamoda, Y., et al., Usefulness of performing a pancreaticojejunostomy with an internal stent after a pancreatoduodenectomy. Surg Today, 2008. 38(6): p. 524–8.
21. Mathur, A., et al., Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg, 2007. 246(6): p. 1058–64.
22. Noun, R., et al., The impact of obesity on surgical outcome after pancreaticoduodenectomy. JOP, 2008. 9(4): p. 468–76.
23. de Castro, S.M., et al., Incidence and management of pancreatic leakage after pancreatoduodenectomy. Br J Surg, 2005. 92(9): p. 1117–23.
24. Cameron, J.L. and J. He, Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg, 2015. 220(4): p. 530–6.
25. Van Buren, G., 2nd, et al., A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage. Ann Surg, 2014. 259(4): p. 605–12.
26. McMillan, M.T., et al., The value of drains as a fistula mitigation strategy for pancreatoduodenectomy: something for everyone? Results of a randomized prospective multi-institutional study. J Gastrointest Surg, 2015. 19(1): p. 21–31.
27. Pratt, W.B., M.P. Callery, and C.M. Vollmer, Jr., The latent presentation of pancreatic fistulas. Br J Surg, 2009. 96(6): p. 641–9.
28. Behrman, S.W., et al., The microbiology of secondary and postoperative pancreatic infections: implications for antimicrobial management. Arch Surg, 2011. 146(5): p. 613–9.
29. Hoos, W.A., et al., Pancreatic cancer clinical trials and accrual in the United States. J Clin Oncol, 2013. 31(27): p. 3432–8.